Skip to content
Flurandrenolide
Cordran (flurandrenolide) is a small molecule pharmaceutical. Flurandrenolide was first approved as Cordran on 1982-01-01. It is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, and leg dermatoses in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Cordran (generic drugs available since 2016-08-30, discontinued: Cordran sp)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Flurandrenolide
Tradename
Company
Number
Date
Products
CORDRANAlmirallN-016455 RX1982-01-01
1 products, RLD, RS
Show 4 discontinued
Flurandrenolide
+
Neomycin sulfate
Tradename
Company
Number
Date
Products
CORDRAN NEli LillyN-050345 DISCN1982-01-01
1 products
CORDRAN NEli LillyN-050346 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
cordranNew Drug Application2023-01-13
flurandrenolideANDA2023-03-15
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
facial dermatoses—D005148—
foot dermatoses—D005533—
hand dermatoses—D006229—
inflammationMP_0001845D007249—
leg dermatoses—D007868—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AC: Corticosteroids, potent (group iii)
— D07AC07: Fludroxycortide
— D07C: Corticosteroids, combinations with antibiotics
— D07CC: Corticosteroids, potent, combinations with antibiotics
— D07CC03: Fludroxycortide and antibiotics
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFLURANDRENOLIDE
INNfludroxycortide
Description
Flurandrenolide is a 21-hydroxy steroid.
Classification
Small molecule
Drug classandrogens
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
Identifiers
PDB—
CAS-ID1524-88-5
RxCUI4500
ChEMBL IDCHEMBL1201012
ChEBI ID—
PubChem CID15209
DrugBankDB00846
UNII ID8EUL29XUQT (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 107 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1 adverse events reported
View more details